These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16494110)

  • 21. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
    Tristano AG; Fuller K
    Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cyclosporin A in inflammatory rheumatic diseases].
    Gross WL; Rob PM
    Internist (Berl); 1996 Jan; 37(1):91-7. PubMed ID: 8837835
    [No Abstract]   [Full Text] [Related]  

  • 23. Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases.
    Thio M; Blokhuis BR; Nijkamp FP; Redegeld FA
    Trends Pharmacol Sci; 2008 Apr; 29(4):170-4. PubMed ID: 18353446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The joint-gut axis in inflammatory bowel diseases.
    Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH
    J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
    Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease.
    Cope AP; Feldmann M
    Curr Opin Immunol; 2004 Dec; 16(6):780-6. PubMed ID: 15511673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational research in inflammatory bowel disease.
    Abreu MT; Sparrow MP
    Mt Sinai J Med; 2006 Dec; 73(8):1067-73. PubMed ID: 17285196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.
    Stefanelli T; Malesci A; De La Rue SA; Danese S
    Autoimmun Rev; 2008 May; 7(5):364-9. PubMed ID: 18486923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases.
    Smith DJ; Vainio PJ
    Ann N Y Acad Sci; 2007 Sep; 1110():382-8. PubMed ID: 17911453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
    Hatoum OA; Heidemann J; Binion DG
    Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunobiology of chronic inflammatory bowel diseases].
    Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2657-60. PubMed ID: 17109275
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helminths and mucosal immune modulation.
    Weinstock JV
    Ann N Y Acad Sci; 2006 Aug; 1072():356-64. PubMed ID: 17057216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.